+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Urokinase receptor expression during hematopoietic maturation



Urokinase receptor expression during hematopoietic maturation



Fibrinolysis 8(Suppl. 1): 51




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144184

Download citation: RISBibTeXText


Related references

Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue. American Journal of Clinical Pathology 102(6): 835-841, 1994

Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor. Journal of Biological Chemistry 269(41): 25668-25676, 1994

Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic a2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor. The Journal of Biological Chemistry 269: 668-76, 1994

Maturation and lineage-specific expression of the coxsackie and adenovirus receptor in hematopoietic cells. Stem Cells 18(3): 176-182, 2000

Expression of the receptor for urokinase-type plasminogen activator in normal cells and neoplastic hematopoietic cells. Tissue Antigens 42(4): 379, 1993

The decrease in cell migration of a derived ovarian carcinoma cell line with defective urokinase production and normal urokinase receptor expression is not corrected by addition of urokinase A possible explanation. Fibrinolysis 8(Suppl. 1): 59, 1994

Invasiveness of esophageal carcinoma cells requires co-expression of urokinase and urokinase receptor. Gastroenterology 112(4 Suppl. ): A619, 1997

Co-expression of urokinase, urokinase receptor and PA1-1 is necessary for optimum invasiveness of cultured lung cancer cells. International Journal of Cancer 60(4): 501-506, 1995

A composite role of vitronectin and urokinase in the modulation of cell morphology upon expression of the urokinase receptor. Journal of Biological Chemistry 283(22): 15217-15223, 2008

Modulation of urokinase and urokinase receptor gene expression in human renal cell carcinoma. American Journal of Pathology 147(1): 183-192, 1995

Gene expression changes of urokinase plasminogen activator and urokinase receptor in rat testes at postnatal stages. Asian Journal of Andrology 9(5): 679-683, 2007

Urokinase, urokinase receptor, and plasminogen activator inhibitor-1 expression on podocytes in immunoglobulin A glomerulonephritis. Korean Journal of Internal Medicine 29(2): 176-182, 2015

Urokinase receptor expression on monocytes and plasma urokinase content are decreased in coronary artery disease. European Heart Journal 18(ABSTR Suppl. ): 631, 1997

Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator. Molecular Carcinogenesis 46(3): 165-175, 2006